1Oeggerli M,Tomovska S,Schraml P,et al.E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer.Oncogene,2004,23(33) :5616 -5623.
2Saavedra HI,Maiti B,Timmers C,et al.Inactivation of E2F3 results in centrosome amplification.Cancer Cell,2003,3 (4) :333 -346.
3Aslanian A,Iaquinta PJ,Verona R,et al.Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.GenesDev,2004,18(12) :1413 -22.
4Doron Ginsberg.E2F3 - a novel repressor of the ARF/p53 pathway.Dev Cell,2004,6(6) :742 -743.
5Ziebold U,Lee EY,Bronson RT,et al.E2F3 loss has opposing effects on different pRB - deficient tumors,resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas.Mol Cell Biol,2003,23 (18) :6542 - 6552.
6Wu L,Timmers C,Maiti B,et al.The E2F1 -3 transcription factors are essential for cellular proliferation.Nature,2001,414 (6862) :457-462.
7Humbert PO,Verona R,Trimarchi JM,et al.E2f3 is critical for normal cellular proliferation.Genes Dev,2000,14 (6) :690 - 703.
8Zhang R,Mayhood T,Lipari P,et al.Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction.Anal Biochem,2004,331(1) :138 -146.
9Le Frere - Belda MA,Gil Diez de Medina S,Daher A,et al.Profiles of the 2 INK4a gene products,p16 and p14ARF,in human reference urothelium and bladder carcinomas ,according to pRb and p53 protein status.Hum Pathol,2004,35 (7):817 - 824.
10Martin Oeggerli,Sanja Tomovska,Peter Schraml,et al.E2F3 amplification and overexpression is associated with invasivetumor growth and rapid tumor cell proliferation in urinary bladder cancer.Oncogene ,2004,23:5616 - 5623.
